Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The DOI matches its Crossref record.
Abstract
Since the 1990 NIH-sponsored conference on polycystic ovary syndrome (PCOS), it has become appreciated that the syndrome encompasses a broader spectrum of signs and symptoms of ovarian dysfunction than those defined by the original diagnostic criteria. The 2003 Rotterdam consensus workshop concluded that PCOS is a syndrome of ovarian dysfunction along with the cardinal features hyperandrogenism and polycystic ovary (PCO) morphology. PCOS remains a syndrome and, as such, no single diagnostic criterion (such as hyperandrogenism or PCO) is sufficient for clinical diagnosis. Its clinical manifestations may include: menstrual irregularities, signs of androgen excess, and obesity. Insulin resistance and elevated serum LH levels are also common features in PCOS. PCOS is associated with an increased risk of type 2 diabetes and cardiovascular events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diagnosis of PCOS was based on the presence of two out of three Rotterdam Criteria: ovulatory dysfunction presenting as irregular menstrual cycles or amenorrhea, clinical and/or biochemical hyperandrogenism, and ultrasound assessment of polycystic ovaries (≥12 antral follicles in one ovary or ovarian volume ≥ 10 mL) [7,21].”
From Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS (2025) · cites this paper as [7]
In the citing paper
“Moran et al. [126] reported reduced testosterone levels following lifestyle intervention but found no effect on FAI (100 × total testosterone/SHBG), a more valid marker of hyperandrogenism [121].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [121]
In the citing paper
“The 2023 international evidence-based PCOS guidelines [3] recommend that a PCOS diagnosis should be based on criteria adapted from the Rotterdam criteria [7]; thus, requiring at least two of (1) clinical/biochemical hyperandrogenism; (2) ovulatory dysfunction; and (3) polycystic ovaries on ultrasound (anti-Mullerian hormone can be used instead of ultrasound) [3].”
From Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review (2024) · cites this paper as [7]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
In the citing paper
“There is no single diagnostic test, different sets of diagnostic criteria are still used, individual diagnostic criteria lack clarity, and exclusion of other etiologies is needed to establish the diagnosis of PCOS (4, 23, 24).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [4]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
Items 301–389 of 389
Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697223 · Cited by 41
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01734-w · Cited by 40
Tagliaferri, V., Romualdi, D., Immediata, V., De Cicco, S., Di Florio, C., Lanzone, A., & Guido, M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13304 · Cited by 40
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
(2014) · doi:10.1586/eem.12.73 · Cited by 40
Lu, C., Cardoso, R. C., Puttabyatappa, M., & Padmanabhan, V. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.136283 · Cited by 40
Aydin, K., Arusoglu, G., Koksal, G., Cinar, N., Yazgan Aksoy, D., & Yildiz, B. O. (2014) · Clinical Endocrinology · doi:10.1111/cen.12468 · Cited by 39
Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38
Polycystic ovary syndrome (PCOS)
Balen, A. H. (2017) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12345 · Cited by 37
Soldat-Stanković, V., Popović-Pejičić, S., Stanković, S., Prtina, A., Malešević, G., Bjekić-Macut, J., Livadas, S., Ognjanović, S., Mastorakos, G., Micić, D., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01691-5 · Cited by 37
Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1484321 · Cited by 37
“-e manifestations of PCOS generally include oligomenorrhea or amenorrhea, abnormal folliculogenesis, chronic anovulation, hyperandrogenemia, and infertility [2].”
BackgroundJurczewska, J., Ostrowska, J., Chełchowska, M., Panczyk, M., Rudnicka, E., Kucharski, M., Smolarczyk, R., & Szostak-Węgierek, D. (2023) · Nutrients · doi:10.3390/nu15163652 · Cited by 37
Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity
Htet, T. D., Teede, H. J., de Courten, B., Loxton, D., Real, F. G., Moran, L. J., & Joham, A. E. (2017) · European Respiratory Journal · doi:10.1183/13993003.01334-2016 · Cited by 34
Taskin, M. I., Bulbul, E., Adali, E., Hismiogulları, A. A., & Inceboz, U. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.03.006 · Cited by 36
Pan, Z., Zhu, F., & Zhou, K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.696879 · Cited by 34
Penaforte, F. R. O., Japur, C. C., Diez-Garcia, R. W., & Chiarello, P. G. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2010.01130.x · Cited by 35
The free androgen index is inaccurate in women when the SHBG concentration is low
Keevil, B. G., Adaway, J., Fiers, T., Moghetti, P., & Kaufman, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13561 · Cited by 35
Is polycystic ovary syndrome a 20th Century phenomenon?
Rodgers, R. J., Suturina, L., Lizneva, D., Davies, M. J., Hummitzsch, K., Irving-Rodgers, H. F., & Robertson, S. A. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.01.019 · Cited by 34
Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study
Lin, T., Li, S., Xu, H., Zhou, H., Feng, R., Liu, W., Sun, Y., & Ma, J. (2015) · Human Reproduction · doi:10.1093/humrep/dev231 · Cited by 34
Papakonstantinou, E., Kechribari, I., Mitrou, P., Trakakis, E., Vassiliadi, D., Georgousopoulou, E., Zampelas, A., Kontogianni, M. D., & Dimitriadis, G. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.225 · Cited by 34
Chen, Y., Yang, D., Li, L., & Chen, X. (2008) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.01.081 · Cited by 34
Huang, X., Wang, Q., Liu, T., Pei, T., Liu, D., Zhu, H., & Huang, W. (2019) · Endocrine · doi:10.1007/s12020-019-01912-1 · Cited by 34
Saadati, N., Haidari, F., Barati, M., Nikbakht, R., Mirmomeni, G., & Rahim, F. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08338 · Cited by 34
Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome
Salama, A., Amine, E., Salem, H. E., & Abd El Fattah, N. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.161246 · Cited by 33
Li, Y., Deng, B., Ouyang, N., Yuan, P., Zheng, L., & Wang, W. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-0929-z · Cited by 32
Li, G., Hu, J., Zhang, S., Fan, W., Wen, L., Wang, G., & Zhang, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603279 · Cited by 32
Zhang, L., Li, H., Li, S., & Zou, X. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.038 · Cited by 32
Coexistence of polycystic ovary syndrome and endometriosis in women with infertility
Holoch, K. J., Savaris, R. F., Forstein, D. A., Miller, P. B., Higdon, H. L., Likes, C. E., & Lessey, B. A. (2014) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000181 · Cited by 30
Brosens, I., & Benagiano, G. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.07.021 · Cited by 31
Uterine Morphology and Peristalsis in Women with Polycystic Ovary Syndrome
Leonhardt, H., Gull, B., Kishimoto, K., Kataoka, M., Nilsson, L., Janson, P. O., Stener-Victorin, E., & Hellström, M. (2012) · Acta Radiologica · doi:10.1258/ar.2012.120384 · Cited by 29
Suri, J., Suri, J. C., Chatterjee, B., Mittal, P., & Adhikari, T. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.02.014 · Cited by 28
Mokaberinejad, R., Rampisheh, Z., Aliasl, J., & Akhtari, E. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1541232 · Cited by 28
A mixed-methods study of coping and depression in adolescent girls with polycystic ovary syndrome
Hopkins, C. S., Kimble, L. P., Hodges, H. F., Koci, A. F., & Mills, B. B. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000125 · Cited by 27
Nutrient Patterns and Risk of Polycystic Ovary Syndrome.
(2019) · Europe PMC (PubMed Central) · Cited by 27
Grassi, G., Polledri, E., Fustinoni, S., Chiodini, I., Ceriotti, F., D’Agostino, S., Filippi, F., Somigliana, E., Mantovani, G., Arosio, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010119 · Cited by 27
Aerobic exercise improves cardiac autonomic modulation in women with polycystic ovary syndrome
Sá, J. C. F., Costa, E. C., da Silva, E., Tamburús, N. Y., Porta, A., Medeiros, L. F., Lemos, T. M. A. M., Soares, E. M. M., & Azevedo, G. D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.031 · Cited by 26
Wen, X., Wang, L., & Bai, E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1370578 · Cited by 25
Antidepressants for polycystic ovary syndrome
Zhuang, J., Wang, X., Xu, L., Wu, T., & Kang, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008575.pub2 · Cited by 25
Peters, H. E., Laeven, C. H. C., Trimbos, C. J. M. A., van de Ven, P. M., Verhoeven, M. O., Schats, R., Mijatovic, V., & Lambalk, C. B. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.06.029 · Cited by 24
Javed, Z., Papageorgiou, M., Madden, L. A., Rigby, A. S., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (2020) · Endocrine Connections · doi:10.1530/ec-20-0173 · Cited by 24
Jiskoot, G., de Loos, A. D., Timman, R., Beerthuizen, A., Laven, J., & Busschbach, J. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00593-y · Cited by 23
ZHU, J., TENG, Y., ZHOU, J., LU, W., TAO, M., & JIA, W. (2013) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12031 · Cited by 23
Is prostate‐specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural, B., Özkan, S., & Bodur, H. (2007) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2007.00507.x · Cited by 23
Gomula, J., Warner, M., & Blandford, A. (2024) · BMC Women's Health · doi:10.1186/s12905-024-02993-5 · Cited by 22
Rajasekaran, K., Malhotra, N., Mahey, R., Khadgawat, R., & Kalaivani, M. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1981282 · Cited by 22
Skiba, M. A., Bell, R. J., Herbert, D., Garcia, A. M., Islam, R. M., & Davis, S. R. (2021) · Human Reproduction · doi:10.1093/humrep/deab069 · Cited by 22
Sarkar, M., Lai, J. C., Sawinski, D., Zeigler, T. E., Cedars, M., & Forde, K. A. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13027 · Cited by 22
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22
The diagnostic experience of polycystic ovary syndrome: A scoping review of patient perspectives
Presswala, B., & De Souza, L. R. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.107771 · Cited by 21
Haimbaugh, A., Meyer, D. N., Connell, M. L., Blount-Pacheco, J., Tolofari, D., Gonzalez, G., Banerjee, D., Norton, J., Miller, C. J., & Baker, T. R. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21121615 · Cited by 21
Modeling Endocrine Control of the Pituitary–Ovarian Axis: Androgenic Influence and Chaotic Dynamics
Hendrix, A. O., Hughes, C. L., & Selgrade, J. F. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-013-9913-7 · Cited by 19
Is cardiorespiratory fitness impaired in PCOS women? A review of the literature
Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20
Khatlani, K., Njike, V., & Costales, V. C. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0049 · Cited by 20
A meta-analysis of the relationship between polycystic ovary syndrome and sleep disturbances risk
Wang, C., Huang, T., Song, W., Zhu, J., Liu, Y., Chen, X., Sun, X., Wu, Q., Chen, H., Liao, H., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.957112 · Cited by 19
Gambineri, A., & Zanotti, L. (2018) · Nucleus · doi:10.1080/19491034.2018.1509659 · Cited by 19
Chung, J. P. W., Yiu, A. K. W., Chung, T. K. H., & Chan, S. S. C. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2013.09.011 · Cited by 16
Ravn, P., Gram, F., Andersen, M. S., & Glintborg, D. (2022) · Metabolites · doi:10.3390/metabo12121183 · Cited by 18
Nahuis, M. J., Oude Lohuis, E. J., Bayram, N., Hompes, P. G. A., Oosterhuis, G. J. E., van der Veen, F., Mol, B. W. J., & van Wely, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.004 · Cited by 18
The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS
Li, X., Yang, D., Pan, P., Azziz, R., Yang, D., Cheng, Y., & Zhao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873726 · Cited by 18
Rodriguez, E. M., Thomas, D., Druet, A., Vlajic-Wheeler, M., Lane, K. J., & Mahalingaiah, S. (2020) · JMIR Formative Research · doi:10.2196/15094 · Cited by 18
BALDANI, D. P., SKRGATIC, L., CERNE, J. Z., OGUIC, S. K., GERSAK, B. M., & GERSAK, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3117 · Cited by 18
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16
Tao, M., Zhou, J., Zhu, J., Lu, W., & Jia, W. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.03.2277 · Cited by 16
Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.14983 · Cited by 16
Dou, P., Zhang, T.-T., Xu, Y., Xue, Q., Zhang, Y., Shang, J., & Yang, X.-L. (2024) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303286777240223074922 · Cited by 15
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Barber, T. M., & Franks, S. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.827373 · Cited by 15
Kudesia, R., Illions, E. H., & Lieman, H. J. (2017) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-016-0454-7 · Cited by 15
Sun, Q., Yuan, G., Yang, J., Lu, J., Feng, W., & Yang, W. (2021) · doi:10.1101/2021.06.29.21259512 · Cited by 15
Zhu, M., Wang, K., Feng, J., Liu, Y., Guan, M., Wang, Y., & Wu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1502321 · Cited by 14
Polycystic Ovary Syndrome and the Internet of Things: A Scoping Review
Graca, S., Alloh, F., Lagojda, L., Dallaway, A., Kyrou, I., Randeva, H. S., & Kite, C. (2024) · Healthcare · doi:10.3390/healthcare12161671 · Cited by 14
Abdalla, M. A., Deshmukh, H., Mohammed, I., Atkin, S., Reid, M., & Sathyapalan, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.652559 · Cited by 14
Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Abdul Jafar, N. K., Al Balushi, A., Subramanian, A., Lee, S. I., Bennett, C. J., Moran, L. J., Mousa, A., Tay, C. T., Teede, H. J., & Mansfield, D. R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1532519 · Cited by 15
“…in adults is based on the presence of two of three features: (i) oligo/ amenorrhea; (ii) clinical/biochemical hyperandrogenism and/or (iii) polycystic ovary morphology (4) or elevated serum anti-Müllerian hormone levels, according to the latest 2023 International Evidence-based PCOS Guideline (1).”
Beyond counting sheep: Exploring the link between polycystic ovary syndrome and sleep health
Jafar, N. K. A., Bennett, C. J., Moran, L. J., & Mansfield, D. R. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777724 · Cited by 12
Moini, A., Arabipoor, A., Hemat, M., Ahmadi, J., Salman-Yazdi, R., & Zolfaghari, Z. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1499084 · Cited by 12
Sathyapalan, T., Cho, L. W., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03345.x · Cited by 11
Polycystic ovarian morphology is associated with primary dysmenorrhea in young Korean women
Jeong, J. Y., Kim, M. K., Lee, I., Yun, J., Won, Y. B., Yun, B. H., Seo, S. K., Cho, S., Choi, Y. S., & Lee, B. S. (2019) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2019.62.5.329 · Cited by 11
Fetal androgen excess provides a developmental origin for polycystic ovary syndrome
Abbott, D. H., & Dumesic, D. A. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.1 · Cited by 11
Wang, C., & Tian, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226387 · Cited by 11
Malhotra, N., Arora, T., Suri, V., Jena, S. K., Verma, A., Gowri, M., Kapoor, N., Chalga, M. S., Kulkarni, B., & Kamath, M. S. (2023) · Trials · doi:10.1186/s13063-023-07466-y · Cited by 10
Hart, K., Barr, S., Reeves, S., Sharp, K., & Jeanes, Y. (2016) · Nutrition & Dietetics · doi:10.1111/1747-0080.12188 · Cited by 9
Insulin, ghrelin and early return of hunger in women with obesity and polycystic ovary syndrome
Japur, C. C., Diez-Garcia, R. W., de Oliveira Penaforte, F. R., das Graças Pena, G., de Araújo, L. B., & de Sá, M. F. S. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.013 · Cited by 8
Tay, C. T., Williams, F., Mousa, A., Teede, H., & Burgert, T. S. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777086 · Cited by 8
Choi, H. K., Lee, S. H., & Yang, S. Y. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16253 · Cited by 6
Lewandowski, K., Głuchowska, M., Garnysz, K., Horzelski, W., Grzesiak, M., & Lewiński, A. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0095 · Cited by 6
Metformin treatment with or without life style changes in patients with polycystic ovary syndrome
Petrányi, G., & Zaoura-Petrányi, M. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29045 · Cited by 5
Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS
Kowalczyk, K., Kadłubek, S., Krużel, A., Sikora, D., Daniluk, J., & Madej, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082708 · Cited by 4
Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
Rani, R., Priyanka, P., Yadav, R., Bajal, N., Mandal, B. S., & Kumar, A. (2024) · International Journal of Environment, Agriculture and Biotechnology · doi:10.22161/ijeab.94.5 · Cited by 4
Liu, X., Wang, F., Wang, X., & Luan, Q. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2405097 · Cited by 4
Islam, R. M., Bell, R. J., Skiba, M. A., & Davis, S. R. (2021) · Clinical Endocrinology · doi:10.1111/cen.14592 · Cited by 2
Metadata
- Authors
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Corresponding author
- The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 41-47
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W4256605237
- Cited by
- 6,138
- References
- 0
- Citations by year
- 2026: 346 · 2025: 412 · 2024: 472 · 2023: 434 · 2022: 419 · 2021: 395 · 2020: 342 · 2019: 326 · 2018: 263 · 2017: 265 · 2016: 226 · 2015: 259 · 2014: 266 · 2013: 249 · 2012: 232
- FWCI
- 76.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, diagnostic criteria, hyperandrogenism, polycystic ovary morphology, ovarian dysfunction, menstrual irregularity, insulin resistance, luteinizing hormone, type 2 diabetes risk, cardiovascular risk, obesity
- MeSH terms
- Clinical Trials as Topic, Consensus Statements as Topic, Female, Humans, Insulin Resistance, Luteinizing Hormone, Polycystic Ovary Syndrome, Risk Factors, United States, Consensus Development Conferences, NIH as Topic, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.